Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TOFACITINIB Cause Gamma-glutamyltransferase increased? 71 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Gamma-glutamyltransferase increased have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.

71
Reports of Gamma-glutamyltransferase increased with TOFACITINIB
0.1%
of all TOFACITINIB reports
1
Deaths
19
Hospitalizations

How Dangerous Is Gamma-glutamyltransferase increased From TOFACITINIB?

Of the 71 reports, 1 (1.4%) resulted in death, 19 (26.8%) required hospitalization, and 4 (5.6%) were considered life-threatening.

Is Gamma-glutamyltransferase increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 71 reports have been filed with the FAERS database.

What Other Side Effects Does TOFACITINIB Cause?

Drug ineffective (30,382) Pain (21,659) Condition aggravated (16,925) Arthralgia (15,640) Fatigue (13,551) Rheumatoid arthritis (12,277) Off label use (11,736) Headache (11,061) Joint swelling (10,686) Malaise (9,040)

What Other Drugs Cause Gamma-glutamyltransferase increased?

FINGOLIMOD (635) ACETAMINOPHEN (442) METHOTREXATE (421) ATORVASTATIN (376) RIBOCICLIB (375) LETROZOLE (323) DEXAMETHASONE (292) CYCLOPHOSPHAMIDE (277) CARBOPLATIN (262) NIVOLUMAB (261)

Which TOFACITINIB Alternatives Have Lower Gamma-glutamyltransferase increased Risk?

TOFACITINIB vs TOFERSEN TOFACITINIB vs TOLNAFTATE TOFACITINIB vs TOLODODEKIN ALFA TOFACITINIB vs TOLTERODINE TOFACITINIB vs TOLVAPTAN

Related Pages

TOFACITINIB Full Profile All Gamma-glutamyltransferase increased Reports All Drugs Causing Gamma-glutamyltransferase increased TOFACITINIB Demographics